Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma.

ABSTRACT: The last two decades have seen the development of effective therapies, which have saved the lives of a large number of melanoma patients. However, therapeutic options are still limited for patients without BRAF mutations or in relapse from current treatments, and severe side effects often occur during therapy. Thus, additional insights to improve treatment efficacy with the aim to decrease the likelihood of chemoresistance, as well as reducing side effects of current therapies, are required. Natural products offer great opportunities for the discovery of antineoplastic drugs, and still represent a useful source of novel molecules. Among them, essential oils, representing the volatile fraction of aromatic plants, are always being actively investigated by several research groups and show pro

SUBMITTER: Di Martile M 

PROVIDER: S-EPMC7565555 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature